Tumours with inappropriate EPO production and secondary erythrocytosis described in the literature are cerebellar hemangioblastomas, meningiomas, pheochromocytoma, uterine leiomyomas, parathyroid adenomas, hepatocellular carcinoma, and renal cell carcinoma [4, 29]. This evidence concerns the gene EPO and hepatocellular carcinoma.